You are here

Article info

Article menu
Download PDFPDF
Case report
Oral ketamine for neuropathic cancer pain

Authors

  • Agnès Calsina-Berna Palliative Care Department, Research and Knowledge Group in Palliative Care of Catalan Institute of Oncology (GRICOPAL), Institut Català d'Oncologia-Badalona, Badalona, Spain PubMed articlesGoogle scholar articles
  • Margarita Alvaro Pardo Palliative Care Department, Institut Català d'Oncologia-Badalona, Badalona, Spain PubMed articlesGoogle scholar articles
  • Marc Cucurull Salamero Medical Oncology Department, Institut Català d’Oncologia – Badalona, Badalona, Spain PubMed articlesGoogle scholar articles
  • Montserrat Bleda-Perez Palliative Care Department, Institut Català d'Oncologia-Badalona, Badalona, Spain PubMed articlesGoogle scholar articles
  • Joaquim Julià-Torras Palliative Care Department, Institut Català d'Oncologia-Badalona, Badalona, Spain Palliative Care Department. Institut Català d'Oncologia-Badalona, Badalona, Spain, School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Badalona, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Agnès Calsina-Berna, Palliative Care Service. Research and knowledge group in palliative care of Catalan Institute of Oncology (GRICOPAL), Institut Català d'Oncologia-Badalona, Badalona, Spain; acalsina{at}iconcologia.net
View Full Text

Citation

Calsina-Berna A, Alvaro Pardo M, Cucurull Salamero M, et al
Oral ketamine for neuropathic cancer pain
BMJ Supportive & Palliative Care 2023;13:e968-e970.

Publication history

  • Received March 29, 2023
  • Accepted April 20, 2023
  • First published May 24, 2023.
Online issue publication 
January 11, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.